… patients older than 70 years is debated. This study examines the outcomes of elderly patients
… However, as our study demonstrates, elderly patients with comorbidities are less likely to …

… chemoradiation is increasingly used for patients with locally advanced head and neck cancer,
many elderly patients … among patients age ≥ 65 who received concurrent chemoradiation …

… Conclusions: Our results demonstrated that CCRT in elderly patients had significant survival
benefit compared to RT alone, especially using Single oral agent. sCCRT had less toxicities …

… therapy (RT) for elderly glioblastoma (GBM) patients. Elderly patients (age >70) with
supratentorial and nonmetastatic GBM who received RT of 20–75 Gy with concurrent single-agent …

… chemoradiotherapy is … elderly patients with LA-NSCLC has not been confirmed yet. We
evaluated the feasibility and efficacy of concurrent chemoradiotherapy (CCRT) for elderly patients …

… sample size of elderly patients or excluded elderly patients. Performing a prospective trial of
elderly patients is difficult because of comorbidities, the rarity of the patients, and decreasing …

… These observations have not consistently been made in patients with other … elderly patients
treated with concurrent chemoradiotherapy have similar survival benefits as younger patients…

… Modern CRT appears to confer a survival benefit compared to chemotherapy alone in a
recent retrospective analysis conducted on elderly patients with LD-SCLC. Age alone should not …

… The standard treatment for LAPC is chemotherapy (CTX) alone or concurrent chemoradiotherapy
(CCRT). A previous study showed that CCRT was associated with decreasing local …

… with MIBC most often are treated with radical cystectomy with or without neoadjuvant or
adjuvant chemotherapy, but bladder-preserving concurrent chemoradiotherapy (CCRT) after …